Non-epithelial Renal Neoplasms of the Adult Kidney

Non-epithelial renal neoplasms are usually incidentally discovered and generally appear as solid enhancing lesions on computerized tomography. Mesenchymal lesions include angiomyolipoma, leiomyoma, hemangioma, solitary fibrous tumor, leiomyosarcoma, synovial sarcoma, and liposarcoma, with appearances and behaviors similar to those arising outside the kidney. Angiomyolipomas are the most common of these entities and classically contain varying amounts of adipose tissue, smooth muscle, and vessels. In contrast to classic angiomyolipoma, epithelioid angiomyolipoma can be associated with a malignant outcome. Other renal-specific mesenchymal renal neoplasms include juxtaglomerular cell tumor and renomedullary interstitial cell tumor, both of which represent benign entities. The primary therapy for most mesenchymal renal neoplasms is surgical excision with concomitant partial or complete resection of adjacent uninvolved structures when locally invasive. Embolization is another option, with chemotherapy and radiation mostly reserved for palliative purposes. In addition to mesenchymal lesions, the kidney may be involved rarely by primary renal lymphoma and have secondary involvement by lymphoma and leukemia. Finally, neuroendocrine lesions may also occur and represent a spectrum of entities ranging from renal carcinoid tumor to small cell carcinoma

Pathological characterization and clinical outcome of penile intraepithelial neoplasia variants: a North American series.

peer reviewedPenile intraepithelial neoplasia (PeIN) is classified as human papillomavirus (HPV)- and non-HPV-related. This classification is associated with distinct morphologic subtypes. The natural history and prognosis of PeIN subtypes are not well known. This study aims to evaluate clinicopathological features, HPV status, and outcome of PeIN subtypes. Eighty-two lesions from 64 patients with isolated PeIN were retrospectively reviewed. Mean age was 59 years. Lesions were multicentric in 34% of patients and affected glans (33%), shaft (26%), and foreskin (20%). Histologically, 22% of patients had coexisting lesions, classified as hybrid and mixed. HPV-related PeIN (97%) included basaloid (59%), warty (8%), warty-basaloid (8%), hybrid (19%) and mixed (3%) types. P16 and HPV positivity occurred in 99% and 82% of lesions, respectively. HPV 16 was more common in basaloid PeIN. Multiple genotypes were detected in 35%, more commonly in hybrid PeIN (P = 0.051). Positive margins occurred in 63% of excisions. PeIN recurred in 48% of excisions and 30% of overall repeated procedures, and progression to invasive carcinoma occurred in 2%. At follow-up, 86% of patients had no evidence of disease and 12% were alive with disease. Lichen sclerosus occurred in non-HPV and HPV-related PeIN (100% and 47%).In conclusion, HPV-related and, more specifically basaloid PeIN were the predominant types and preferentially associated with HPV 16. While PeIN had a high recurrence rate, there was a slow and infrequent progression to invasive or metastatic carcinoma with multimodal treatments. Additional studies are needed to understand biology and natural history of PeIN

Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: Correlative analysis from a large North American cooperative group trial

10.1182/blood-2012-09-454694Blood121183547-3553BLOO

Circulating clonotypic B cells in classic Hodgkin lymphoma

Although Hodgkin and Reed-Sternberg (HRS) cells are B lymphoid cells, they are unlike any normal cells of that lineage. Moreover, the limited proliferative potential of HRS cells belies the clinical aggressiveness of Hodgkin lymphoma (HL). More than 20 years ago, the L428 HL cell line was reported to contain a small population of phenotypic B cells that appeared responsible for the continued generation of HRS cells. This observation, however, has never been corroborated, and such clonotypic B cells have never been documented in HL patients. We found that both the L428 and KM-H2 HL cell lines contained rare B-cell subpopulations responsible for the generation and maintenance of the predominant HRS cell population. The B cells within the HL cell lines expressed immunoglobulin light chain, the memory B-cell antigen CD27, and the stem cell marker aldehyde dehydrogenase (ALDH). Clonal CD27+ALDHhigh B cells, sharing immunoglobulin gene rearrangements with lymph node HRS cells, were also detected in the blood of most newly diagnosed HL patients regardless of stage. Although the clinical significance of circulating clonotypic B cells in HL remains unclear, these data suggest they may be the initiating cells for HL